Bio-Connect

InVivoMAb anti-mouse BTLA (CD272)

BE0304
Bio X Cell
ApplicationsFlow Cytometry, Other Application
Product group Antibodies
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Bio X Cell
  • Product Name
    InVivoMAb anti-mouse BTLA (CD272)
  • Delivery Days Customer
    7
  • Applications
    Flow Cytometry, Other Application
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    6F7
  • Concentration
    4-11 mg/ml
  • Estimated Purity
    >95%
  • Host
    Mouse
  • Isotype
    IgG1
  • Storage Instruction
    2°C to 8°C
  • UNSPSC
    12352203

References

  • Zelinskyy G, Myers L, Dietze KK, et al. Virus-specific CD8+ T cells upregulate programmed death-1 expression during acute friend retrovirus infection but are highly cytotoxic and control virus replication. J Immunol. 2011,187(7):3730-7. doi: 10.4049/jimmunol.1101612
    Read this paper
  • Truong W, Hancock WW, Plester JC, et al. BTLA targeting modulates lymphocyte phenotype, function, and numbers and attenuates disease in nonobese diabetic mice. J Leukoc Biol. 2009,86(1):41-51. doi: 10.1189/jlb.1107753
    Read this paper
  • Steinberg MW, Turovskaya O, Shaikh RB, et al. A crucial role for HVEM and BTLA in preventing intestinal inflammation. J Exp Med. 2008,205(6):1463-76. doi: 10.1084/jem.20071160
    Read this paper
  • Truong W, Plester JC, Hancock WW, et al. Combined coinhibitory and costimulatory modulation with anti-BTLA and CTLA4Ig facilitates tolerance in murine islet allografts. Am J Transplant. 2007,7(12):2663-74.
    Read this paper
  • Hurchla MA, Sedy JR, Gavrieli M, et al. B and T lymphocyte attenuator exhibits structural and expression polymorphisms and is highly Induced in anergic CD4+ T cells. J Immunol. 2005,174(6):3377-85.
    Read this paper